Funding Clinical Trials
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell-based treatments for challenging disease indications to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
Disease Areas |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
|
Crystal Mackall | Stanford University | Phase 1 | Recruiting | 57 | |
|
Thomas Kipps | University of California, San Diego | Phase 1/2 | Recruiting | 156 | |
|
Michael Pulsipher | Children's Hospital of Los Angeles | Phase 1/2 | Launching | N/A | |
| Paul Finnegan | Angiocrine Bioscience, Inc. | Phase 1 | Launching | N/A | ||
| Thomas Kipps | University of California, San Diego | Phase 1 | Active, not recruiting | 29 | ||
| Irving Weissman | Stanford University | Phase 1 | Active, not recruiting | 88 | ||
|
Mehrdad Abedi | University of California, Davis | Phase 1/2 | Recruiting | 18 | |
|
Colleen Delaney | Nohla Therapeutics Inc | Phase 2 | Recruiting | 220 | |
|
Mark Chao | Forty Seven Inc. | Phase 1 | Recruiting | 96 | |
|
Matthew Spear | Poseida Therapeutics, Inc. | Phase 1 | Recruiting | 40 |